FDA approves oral formulation of edaravone for ALS | Carrick Pharmacy
(Carrick Pharmacy News) The US Food and Drug Administration (FDA) has approved an oral formulation for an amyotrophic lateral sclerosis (ALS) treatment. This new approval is found under the name Radicava ORS (edaravone). It is available as a suspension that is taken by mouth in the morning. This new approval is the oral version of …
FDA approves oral formulation of edaravone for ALS | Carrick Pharmacy Read More »